Premium
Therapy of other bacterial infections
Author(s) -
Werlinger Kelly D.,
Moore Angela Yen
Publication year - 2004
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/j.1396-0296.2004.04053.x
Subject(s) - microbiology and biotechnology , medicine , treponema , haemophilus influenzae , haemophilus ducreyi , staphylococcus aureus , neisseria , haemophilus , yersinia pestis , phage therapy , pasteurella multocida , bacteria , virology , virulence , biology , antibiotics , pasteurellaceae , syphilis , escherichia coli , genetics , human immunodeficiency virus (hiv) , biochemistry , bacteriophage , gene
Cutaneous bacterial disease continues to account for a significant proportion of clinical visits. The continuing emergence of strains that are resistant to available antibacterial agents creates a challenge for dermatologists, who need to keep abreast of current treatment strategies. In this article, antibacterial regimens are presented for skin infections caused by organisms such as Staphylococcus, Streptococcus , Pseudomonas , Neisseria , Haemophilus ducreyi , Treponema pallidum , Bacillus anthracis, Yersinia pestis , Pasteurella multocida , Vibrio vulnificus , Actinomyces , and Nocardia .